Mebihusk 200 Capsule contains Mebeverine 200 mg (Modified Release), a direct-acting antispasmodic used to relieve symptoms of irritable bowel syndrome (IBS) and other gastrointestinal disorders characterized by abdominal cramps, bloating, and discomfort. It works by relaxing the smooth muscles of the gut, reducing spasms and easing pain without affecting normal intestinal movement.
Mebeverine is highly effective for individuals suffering from chronic functional bowel disorders such as IBS, spastic colitis, and functional dyspepsia. By targeting intestinal muscles, it helps alleviate pain, cramping, and irregular bowel habits that result from abnormal contractions in the digestive tract.
The modified-release formulation of Mebihusk 200 ensures a gradual release of the active ingredient, providing prolonged relief with fewer doses per day. This makes it an ideal treatment option for long-term management of gastrointestinal discomfort. Unlike traditional antispasmodics, it does not cause drowsiness, making it suitable for daily use without affecting routine activities.
Regular use of Mebihusk 200 Capsule under medical supervision helps improve digestive comfort, reduces the frequency of IBS flare-ups, and enhances overall gastrointestinal health.